scholarly journals Mid-term assessment of mass drug administration for elimination of lymphatic filariasis: in Bundelkhand region of Madhya Pradesh

2019 ◽  
Vol 6 (2) ◽  
pp. 750
Author(s):  
Ram K. Panika ◽  
Rakesh K. Mahore
Keyword(s):  
Lymphatic Filariasis ◽  
Drug Administration ◽  
Mass Drug Administration ◽  
Compliance Rate ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Active Involvement ◽  
Change Communication ◽  
Disability Adjusted Life ◽  
Life Years

Background: Lymphatic filariasis is a vector borne parasitic disease caused by lymphatic dwelling nematode parasite. It is one of the world's leading causes of permanent and long-term disability with an estimated 5.1 million disability adjusted life years (DALYs) are lost due to this disease. The National Health Policy 2002 aims at Elimination of Lymphatic filariasis by 2015 through Annual Mass Drug Administration (MDA) of single dose of DEC. Objective was to assess coverage and compliance of MDA Program and awareness about lymphatic filariasis in Chhatarpur district of Madhya Pradesh.Methods: Cross-sectional Study was conducted. Total 120 households were surveyed in four selected clusters of Chhatarpur district of MP.Results: Out of total 835 persons only 94.37% persons were eligible and 47 (5.62%) were not eligible for MDA for MDA. Coverage rate was 90.22% and compliance rate was 75.24%. The main reason for non-compliance was not having the concerned disease 34.38 % followed by fear of side effect (24.90%). Only 37.5% among the surveyed families were aware about MDA. Majority of respondent 21 (46.66%) acquired knowledge from health workers.Conclusions: The compliance of MDA program was low and the awareness about the lymphatic filariasis in the study population was limited in Chhatarpur district. Poor compliance of MDA is attributed to inadequate consumption of drugs due to poor awareness among eligible population. For elimination of lymphatic filariasis active involvement of community is very essential. It can be made possible through behavior change communication and health education of people.

scholarly journals Evaluation of coverage, compliance of mass drug administration and assessment of awareness about lymphatic filariasis in Tikamgarh district of Madhya Pradesh: a cross sectional study

2019 ◽  
Vol 6 (3) ◽  
pp. 1235
Author(s):  
Ram Kumar Panika ◽  
Rupesh Sahu
Keyword(s):  
Lymphatic Filariasis ◽  
Drug Administration ◽  
Mass Drug Administration ◽  
Compliance Rate ◽  
Public Health Problem ◽  
Cross Sectional Study ◽  
Major Public Health Problem ◽  
Sectional Study ◽  
Cross Sectional ◽  
Life Years

Background: Lymphatic filariasis is the second leading cause of disability worldwide accounting for more than 5 million disability adjusted life years annually. It has been a major public health problem in India which leads to irreversible chronic manifestations which are responsible for considerable economic loss and severe physical disability to the affected individuals. Mass drug administration (MDA) means administration of diethylcarbamazine and albendazole tablets to all people (excluding children <2 years, pregnant women, seriously ill persons) in endemic areas once in a year. The objective of the study was to assess coverage, compliance of MDA and awareness about lymphatic filariasis in Tikamgarh district of Madhya Pradesh.Methods: Cross-sectional study was conducted and total 120 households were surveyed in four randomly selected clusters of Tikamgarh district of Madhya Pradesh.Results: Out of total 743 persons 678 (91.25%) persons were eligible for MDA. Coverage rate was 86.57% and compliance rate was 74.27%. The main reason for non-compliance was not having the concerned disease (55.78%) followed by fear of side effect (22.31%). Only 40.83% among the surveyed families were aware about MDA and only 45.83% respondents had heard about lymphatic filariasis.Conclusions: There is coverage and compliance gap and awareness about the lymphatic filariasis and MDA program is limited. Drug compliance need to be improved and awareness need to be raised. MDA program should not be confined to tablet distribution only and due importance should be given to compliance rate.

Non-compliance to Mass Drug Administration Associated with the Low Perception of the Community Members About their Susceptibility to Lymphatic Filariasis in Ankobra, Ghana

2020 ◽  
Vol 20 (2) ◽  
pp. 167-174
Author(s):  
Ilo Dicko ◽  
Yaya Ibrahim Coulibaly ◽  
Modibo Sangaré ◽  
Bismark Sarfo ◽  
Priscillia Awo Nortey
Keyword(s):  
Lymphatic Filariasis ◽  
Drug Administration ◽  
Mass Drug Administration ◽  
Health Workers ◽  
Compliance Rate ◽  
Cross Sectional Study ◽  
Cluster Sampling ◽  
Cross Sectional ◽  
Improve Compliance ◽  
Degree Of Association

Background: Lymphatic filariasis (LF) is a parasitic disease that has been targeted for elimination through the Mass Drug Administration (MDA.) Although the MDA started in the Ankobra community in Ghana in 2000, LF prevalence as reported in 2014 was relatively high (4.5%). Non-compliance to the MDA has been associated with the persistent LF prevalence in endemic regions. Objective: This study determined the factors associated with the non-compliance to the MDA among patients living in the Ankobra community, Ghana. Methods: A cross-sectional study using a one-stage cluster sampling method was used to collect data between June and July, 2017 in Ankobra. Questionnaires were used to collect data from health workers, the MDA drug distributors and study participants in Ankobra. Data analysis was performed using STATA 14. Logistic regression was used to measure the degree of association between the dependent (non-compliance) and independent variables. Non-compliance rate was defined as the percentage of individuals who self-reported that they did not actually swallow the drugs provided during the MDA. Results: The MDA coverage and non-compliance rates were 73.5% (147/200) and 33.33% (49/147) respectively. The main reason for non-compliance was fear of drug adverse events (75.51%, 37/49). Thought of “not being susceptible to LF” was significantly associated with the non-compliance (aOR= 2.83, [CI= 1.15, 6.98]). Conclusion: Health education about the susceptibility of residents getting LF disease in endemic community must be intensified to improve compliance to MDA medication ingestion and thus meet the Global Elimination of Lymphatic Filariasis by 2020.

scholarly journals Evaluation of coverage and compliance to mass drug administration for lymphatic filariasis elimination in two endemic districts of Karnataka

2019 ◽  
Vol 6 (8) ◽  
pp. 3583
Author(s):  
Anwith H. Shivalingaiah ◽  
Ravikumar K. ◽  
Sunil M. Gurupadaswamy
Keyword(s):  
Lymphatic Filariasis ◽  
Drug Administration ◽  
Mass Drug Administration ◽  
Compliance Rate ◽  
Household Survey ◽  
Cross Sectional Study ◽  
Coverage Rate ◽  
Cross Sectional ◽  
Effective Coverage ◽  
Multi Stage

Background: Lymphatic filariasis is a debilitating and disfiguring disease causing significant socioeconomic burden. India is endemic for filariasis which includes Kalaburagi and Yadgir districts in Karnataka. India has the target for filariasis elimination by 2020 and mass drug administration [MDA] is a strategy for elimination. The objective of the study was to evaluate the coverage and compliance of mass drug administration against lymphatic filariasis.Methods: The study was a cross sectional study conducted during the month of October 2018 in Kalaburagi and Yadgir districts. The study subjects included all the residents of cluster except subjects aged below 2 years and pregnant women. Multi stage sampling was used and three clusters from rural area and one cluster from urban area from each district. Data collection was done by household survey after informed consent using a standard questionnaire.Results: A total population of 1,963 subjects residing in 399 houses of two districts was included. Majority of the study subjects 1517 (77.27%) were in the age group of more than 15 years with predominantly males 984(50.12%). The coverage rate and compliance rate of MDA was 83.17% and 92.46% in Kalaburagi district and 86.71% and 86.98% in Yadgir district respectively. The effective coverage rate and coverage compliance gap was 76.89% and 7.53% in Kalaburagi district, 75.42% and 13.01% in Yadgir district. Incomplete dose of MDA was consumed by 17 subjects in Kalaburagi district and 21 subjects in Yadgir district.Conclusions: The effective MDA coverage in both the study districts is below 85% which is not satisfactory.

Awareness and Coverage of Mass Drug Administration for Elimination of Lymphatic Filariasis: A Community Based Cross Sectional Study in Nepal

2014 ◽  
Vol 40 (1) ◽  
pp. 34-40 ◽  
Author(s):  
Ram Kumar Adhikari ◽  
Jeevan Bahadur Sherchand ◽  
Shiva Raj Mishra ◽  
Kamal Ranabhat ◽  
Rajendra Raj Wagle
Keyword(s):  
Lymphatic Filariasis ◽  
Drug Administration ◽  
Mass Drug Administration ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Community Based ◽  
Cross Sectional

scholarly journals Lymphatic Filariasis Profile in Dumka District of Jharkhand, India

2021 ◽  
Vol 8 (11) ◽  
pp. 364-369
Author(s):  
Vikas Oraon ◽  
Vidushi Topno
Keyword(s):  
Lymphatic Filariasis ◽  
Drug Administration ◽  
Mass Drug Administration ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Community Based ◽  
Cross Sectional ◽  
Male And Female ◽  
Disease Spectrum

Lymphatic filariasis is a mosquito born disease infecting over 120 million people globally. This is a community based cross-sectional study done to assess the prevalence of disease in Dumka District of Jharkhand. Three years data (2018-2020) were used to know the disease spectrum in this region. The disease mostly presented itself in its chronic forms. Prevalence of the disease has decreased in three years duration. Lymphedema cases were predominant as it was seen in both male and female. The study showed Lymphedema cases as 52% in 2018, 88% in 2019 and 98% in 2020. Overall disease is significantly higher in males than in female. But, Elephantiasis is more frequent in females. Present study reveals that there is remarkable impact of ELF program showing significant reduction in number of cases in three years duration. But the study indicates that the disease still continues to be the major cause of disability and poverty. Keywords: Lymphatic filariasis, Mass drug administration, Elimination of Lymphatic Filariasis.

scholarly journals A study to assess mass drug administration of DEC for filaria control in district Satna, Madhya Pradesh: a mid term assessment

2018 ◽  
Vol 5 (3) ◽  
pp. 1201
Author(s):  
Vivek Sharma ◽  
Vikrant Kabirpanthi
Keyword(s):  
Lymphatic Filariasis ◽  
Drug Administration ◽  
Mass Drug Administration ◽  
Public Health Problem ◽  
Wuchereria Bancrofti ◽  
Cross Sectional Study ◽  
Urban Site ◽  
Major Public Health Problem ◽  
Sectional Study ◽  
Cross Sectional

Background: Lymphatic filariasis is a major public health problem which is caused by Wuchereria Bancrofti and Brugia Malai. The disease is endemic in 250 districts in 20 states and UTs. In India national health policy 2002 envisages elimination of lymphatic filariasis by 2015. Important strategy for elimination of lymphatic filariasis is through annual mass drug administration of single dose of DEC for 5 year or more to the eligible population. Present cross sectional study was carried out to assess drug compliance after mass drug administration of DEC and the factors responsible for poor compliance among the population of Satna district of MP.Methods: The present study was a cross-sectional study which was carried out in filarial endemic Satna district. In this district 120 houses from 3 CHC & one urban ward was randomly selected. 30 households each from 3 rural and one urban site were interviewed related to MDA for DEC.Results: Coverage of tablet distribution in Satna was 90.9%. Consumption of drug among the people who received the drug was 87.97%, while the total effective consumption was 79.9%. Drug distributors ensured consumption of drug in only 16.9%.Conclusions: Focus of MDA is primarily to mere distribution of drug. There is need to give emphasis on consumption of drug, health education, common side effects and its management in order to increase effective coverage rate. 

scholarly journals Mass Drug Administration for Lymphatic Filariasis Elimination in Two Districts of North Karnataka: Coverage and Compliance Assessment

Healthline ◽  
2020 ◽  
Vol 11 (2) ◽  
pp. 94-99
Author(s):  
Huluvadi Shivalingaiah Anwith ◽  
S R Suhas ◽  
Seema K S ◽  
Karishma P S ◽  
K Ravi Kumar ◽  
...  
Keyword(s):  
Lymphatic Filariasis ◽  
Drug Administration ◽  
Mass Drug Administration ◽  
Compliance Rate ◽  
Household Survey ◽  
Control Programme ◽  
Coverage Rate ◽  
Cross Sectional ◽  
Effective Coverage ◽  
All Diseases

Introduction: Lymphatic filariasis or elephantiasis is the most debilitating and disfiguring scourge among all diseases which imposes severe social and economic burden. Currently an estimated 63crores people are at a risk of filariasis in 256 endemic districts across 16 states and 5 union territories in India. National filarial control programme is operational since 1955 in India and the current goal is achieving elimination of filariasis by 2020through Mass Drug Administration (MDA). Objective: To assess the coverage, compliance and causes for noncompliance of MDA in the study districts. Method: A cross sectional descriptive study was conducted in October 2019 and January 2020 in Koppal and Bidar districts respectively. Randomly four clusters were selected, three from rural area and one from urban area. All the residents of a cluster were included except subjects aged below 2 years and pregnant women. Data collection was done by household survey using a standard questionnaire. Results: Total populations of 2043 subjects residing in 480 houses were included. The coverage rate was95.44 &94.73% with compliance rate of 91.61% &93.12% in Koppal & Bidar districts, respectively. The effective coverage rate was 87.44 %& 88.2% in Koppal & Bidar districts respectively. Drug consumption by DOT was 95.1% in Koppal&85.8% in Bidar district. Conclusions: The coverage& compliance of MDA was found to be satisfactoryas it was >65%.Consumption of MDA by DOT to be more emphasized to reduce coverage compliance gap and increase the effective coverage rate.

scholarly journals Coverage and compliance of mass drug administration for elimination of lymphatic filariasis in Khammam district

2018 ◽  
Vol 5 (12) ◽  
pp. 5121
Author(s):  
Rajeshwar Rao Alwala ◽  
Chandrasekhar Reddy Bolla ◽  
Shankar Reddy Dudala ◽  
Y. Pravin Raju ◽  
Raston Mondal ◽  
...  
Keyword(s):  
Lymphatic Filariasis ◽  
Drug Administration ◽  
Mass Drug Administration ◽  
Compliance Rate ◽  
Population Based ◽  
Economic Problem ◽  
Coverage Rate ◽  
Systematic Sampling ◽  
Cross Sectional ◽  
Effective Coverage

Background: Lymphatic filariasis (LF) is an important public health and socio-economic problem in the world and it was identified as one of the six diseases, which could be targeted for elimination /eradication. Annual mass drug administration of DEC with selective vector control could result in the effective elimination of infection by interruption of transmission. The present study aimed to find the coverage and compliance of mass drug administration (MDA) of diethyl-carbamazine (DEC) for elimination of lymphatic filariasis (LF) in Khammam district in November 2009.Methods: Cross-sectional, population-based, house-to-house survey was conducted after the round of MDA with DEC. Multi-stage systematic sampling method was used and four clusters were selected with 30 houses in each. A pretested questionnaire was used to interview the study participants. The data collected was analyzed and coverage rate, compliance rate and effective coverage rate were calculated.Results: The coverage rate was 65.54% with variation across different areas. The compliance with drug ingestion was 71.14%. The effective coverage (46.63%) was much below the target (85%) which has to be targeted by intensive information, education and communication (IEC). Side effects of DEC were minimum, transient and drug-specific.Conclusions: The coverage, compliance, and effective coverage rates were found to be lower than the target, which need to be intensified by extensive IEC. 

scholarly journals Coverage evaluation surveys following soil-transmitted helminthiasis and schistosomiasis mass drug administration in Wolaita Zone of Ethiopia—The Geshiyaro project

PLoS ONE ◽  
2021 ◽  
Vol 16 (12) ◽  
pp. e0260722
Author(s):  
Ewnetu Firdawek Liyew ◽  
Melkie Chernet ◽  
Habtamu Belay ◽  
Rosie Maddren ◽  
Toby Landeryou ◽  
...  
Keyword(s):  
Drug Administration ◽  
Mass Drug Administration ◽  
Cross Sectional Study ◽  
World Health ◽  
Size Analysis ◽  
Preventive Chemotherapy ◽  
Cross Sectional ◽  
Change Communication ◽  
Sanitation And Hygiene ◽  
Health Organization

Introduction The Geshiyaro project aims to break transmission of soil-transmitted helminths and schistosomiasis in the Wolaita Zone of Ethiopia through a combination of two interventions: behavior change communication (BCC) for increased water, sanitation and hygiene (WaSH) infrastructure use alongside preventive chemotherapy (PC) using albendazole (ALB) and praziquantel (PZQ), targeted to reach 90% treatment coverage. Coverage evaluation surveys (CES) were conducted post-treatment, and the resultant survey coverage was compared to reported administrative coverage. This provided a secondary confirmation of the Geshiyaro project coverages, and is used to monitor the success of each Mass Drug Administration (MDA) round. Methods A community-based cross-sectional study was conducted in 13 woredas (districts) of the Wolaita Zone. All eligible individuals from the selected households were invited for an interview. The study design, sample size, analysis and report writing were conducted according to the World Health Organization (WHO) CES guidelines for PC. Results The study interviewed a total of 3,568 households and 18,875 individuals across 13 woredas in the Wolaita Zone. Overall, the survey coverage across all studied woredas was 81.5% (95% CI; 80.9–82.0%) for both ALB and PZQ. Reported administrative coverage across all studied woredas was higher than survey coverage, 92.7% and 91.2% for ALB and PZQ, respectively. A significant portion of individuals (17.6%) were not offered PC. The predominant reason for not achieving the target coverage of 90% was beneficiary absenteeism during MDA (6.6% ALB, 6.8% PZQ), followed by drug distributors failing to reach all households (4.7% ALB, 4.8% PZQ), and beneficiaries not informed of the program (1.3% ALB, 1.7% PZQ). Conclusion Programmatic actions will need to be taken during the next MDA campaign to achieve the targeted Geshiyaro project coverage threshold across data collection and program engagement. Adequate training and supervision on recording and reporting administrative coverage should be provided, alongside improved social mobilization of treated communities to increase participation, and strengthened institutional partnerships and communication.

Sign in / Sign up

Export Citation Format

Share Document